SMi’s 4th annual Pharmaceutical Microbiology conference takes place on the 21st-22nd January 2015 in London, UK.

LONDON, ENGLAND, UNITED KINGDOM, December 10, 2014 /EINPresswire.com/ -- SMi is proud to announce that Phil Duncanson, Director of QC & Microbiology at MedImmune will provide a keynote presentation on: Mould Contamination in Pharmaceutical Drug Products at the 4th annual Pharmaceutical Microbiology conference, taking place next month in London, UK.

When asked what attendees would take away from his talk he said: "They will benefit from my experiences trying to diagnose the source of mould in a clean room facility. They will have a fresh perspective on what it takes to remediate a facility with mould recovery issues"

On what he believed the most interested topics were for next year he commented: "There is a lot of noise in microbiology right now around stressed microorganisms; how to stress them and when to use them, so I’m very interested in the stressed and objectionable organism’s session. I’m also interested in the risk assessment presentation from Tim Eaton as applying patient risk to aseptic manufacturing can be a complex subject."

The full interview is available to read in the event download centre.

SMi’s Pharmaceutical Microbiology 2015 conference will bring together an expert and highly accredited speaker line up including over 10 pharma speakers who will spotlight on topical areas such as microbial risk assessment, biofilms in water, sterilisation and validation processes, bioburden control, technological advancements, DNA-based sequencing methods and rapid microbiology methods.

Pharmaceutical Microbiology 2015 will provide attendees with the opportunity to, look for solutions for controlling outbreaks, learn from product recall case studies, explore sterile process validation requirements in submissions or evaluate microbiology within the manufacturing process. Furthermore, this event will draw from expert opinions, showcase the latest technology and inform attendees of new strategies and best practice in the prevention, detection and management of microorganisms.

A Snapshot of Attendees Include:

• Abbott Biologicals
• AstraZeneca
• Battelle Memorial Institute
• BGH International
• Excellent Pharma Consulting
• Fame Pharmaceuticals
• Genzyme Therapeutics
• GlaxoSmithKline
• Hyglos GmbH
• MedImmune
• Merck Serono
• Merial Sas
• MHRA
• Novartis Vaccines
• Sanofi Pharma
• STERIS Corporation
• Synergy Health
• Wickham Laboratories

Plus many more...

For more information visit www.pharma-microbiology.com

Pharmaceutical Microbiology
21 -22 January 2015
Marriott Regents Park Hotel, London UK
www.pharma-microbiology.com

--- End ---

About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries.
We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. We hold events in over 30 major cities throughout the world including London, Paris and Singapore and to date have welcomed over 200,000 participants from 80 countries. More information can be found at http://www.smi-online.co.uk

Teri Arri
SMi Group Ltd
+44 (0) 20 7827 6162
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.